{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:23:03Z","timestamp":1773660183235,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":73,"publisher":"Springer New York","isbn-type":[{"value":"9781493970254","type":"print"},{"value":"9781493970278","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-1-4939-7027-8_4","type":"book-chapter","created":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T13:44:10Z","timestamp":1503927850000},"page":"53-83","source":"Crossref","is-referenced-by-count":25,"title":["Bioinformatics Meets Biomedicine: OncoFinder, a Quantitative Approach for Interrogating Molecular Pathways Using Gene Expression Data"],"prefix":"10.1007","author":[{"given":"Anton A.","family":"Buzdin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Prassolov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex A.","family":"Zhavoronkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolay M.","family":"Borisov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,29]]},"reference":[{"key":"4_CR1","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.4161\/cc.25062","volume":"12","author":"MV Blagosklonny","year":"2013","unstructured":"Blagosklonny MV (2013) MTOR-driven quasi-programmed aging as a disposable soma theory: blind watchmaker vs. intelligent designer. Cell Cycle 12:1842\u20131847","journal-title":"Cell Cycle"},{"key":"4_CR2","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.4161\/cc.10.10.15789","volume":"10","author":"ZN Demidenko","year":"2011","unstructured":"Demidenko ZN, Blagosklonny MV (2011) The purpose of the HIF-1\/PHD feedback loop: to limit mTOR-induced HIF-1\u03b1. Cell Cycle 10:1557\u20131562","journal-title":"Cell Cycle"},{"key":"4_CR3","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.4161\/cc.10.14.16819","volume":"10","author":"MV Blagosklonny","year":"2011","unstructured":"Blagosklonny MV (2011) The power of chemotherapeutic engineering: arresting cell cycle and suppressing senescence to protect from mitotic inhibitors. Cell Cycle 10:2295\u20132298","journal-title":"Cell Cycle"},{"key":"4_CR4","doi-asserted-by":"crossref","first-page":"D214","DOI":"10.1093\/nar\/gkq1020","volume":"39","author":"UniProt Consortium","year":"2011","unstructured":"UniProt Consortium (2011) Ongoing and future developments at the Universal Protein Resource. Nucleic Acids Res 39:D214\u2013B219","journal-title":"Nucleic Acids Res"},{"key":"4_CR5","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1186\/1471-2105-7-S5-S19","volume":"7","author":"S Mathivanan","year":"2006","unstructured":"Mathivanan S, Periaswamy B, Gandhi T, Kandasamy K et al (2006) An evaluation of human protein-protein interaction data in the public domain. BMC Bioinformatics 7:S19","journal-title":"BMC Bioinformatics"},{"key":"4_CR6","unstructured":"Pathway central, a Qiagen portal. https:\/\/www.qiagen.com\/ro\/shop\/genes-and-pathways\/pathway-central\/ . Accessed 15 Mar 2016"},{"key":"4_CR7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/msb.2009.47","volume":"5","author":"A Bauer-Mehren","year":"2009","unstructured":"Bauer-Mehren A, Furlong LI, Sanz F (2009) Pathway databases and tools for their exploitation: benefits, current limitations and challenges. Mol Syst Biol 5:290","journal-title":"Mol Syst Biol"},{"key":"4_CR8","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/bioinformatics\/btg290","volume":"19","author":"A Nikitin","year":"2003","unstructured":"Nikitin A, Egorov S, Daraselia N, Mazo I (2003) Pathway studio\u2014the analysis and navigation of molecular networks. Bioinformatics 19:2155\u20132157","journal-title":"Bioinformatics"},{"key":"4_CR9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-2105-9-110","volume":"9","author":"R Elkon","year":"2008","unstructured":"Elkon R, Vesterman R, Amit N (2008) SPIKE\u2014a database, visualization and analysis tool of cellular signaling pathways. BMC Bioinformatics 9:110","journal-title":"BMC Bioinformatics"},{"key":"4_CR10","doi-asserted-by":"crossref","first-page":"D472","DOI":"10.1093\/nar\/gkt1102","volume":"42","author":"R Haw","year":"2014","unstructured":"Haw R, Stein L (2014) The Reactome pathway knowledgebase. Nucleic Acids Res 42:D472\u2013D477","journal-title":"Nucleic Acids Res"},{"key":"4_CR11","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gks1239","volume":"41","author":"A Nakaya","year":"2013","unstructured":"Nakaya A, Katayama T, Itoh M, Hiranuka K et al (2013) KEGG OC: a large-scale automatic construction of taxonomy-based ortholog clusters. Nucleic Acids Res 41:D353\u2013D357","journal-title":"Nucleic Acids Res"},{"key":"4_CR12","unstructured":"HumanCyc: encyclopedia of human genes and metabolism. http:\/\/www.humancyc.org\/ . Accessed 15 Mar 2016"},{"key":"4_CR13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1089\/omi.2012.0083","volume":"17","author":"JC Vivar","year":"2013","unstructured":"Vivar JC, Pemu P, McPherson R, Ghosh S (2013) Redundancy control in pathway databases (ReCiPa): an application for improving gene-set enrichment analysis in Omics studies and \u201cBig data\u201d biology. OMICS 17:414\u2013422","journal-title":"OMICS"},{"key":"4_CR14","doi-asserted-by":"crossref","first-page":"e0149743","DOI":"10.1371\/journal.pone.0149743","volume":"11","author":"O Eikrem","year":"2016","unstructured":"Eikrem O, Beisland C, Hjelle K, Flatberg A et al (2016) Transcriptome sequencing (RNAseq) enables utilization of formalin-fixed, paraffin-embedded biopsies with clear cell renal cell carcinoma for exploration of disease biology and biomarker development. PLoS One 11:e0149743","journal-title":"PLoS One"},{"key":"4_CR15","doi-asserted-by":"crossref","first-page":"e1002375","DOI":"10.1371\/journal.pcbi.1002375","volume":"8","author":"P Khatri","year":"2012","unstructured":"Khatri P, Sirota M, Butte AJ (2012) Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol 8:e1002375","journal-title":"PLoS Comput Biol"},{"key":"4_CR16","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/bioinformatics\/bti565","volume":"21","author":"P Khatri","year":"2005","unstructured":"Khatri P, Dr\u0103ghici S (2005) Ontological analysis of gene expression data: current tools, limitations, and open problems. Bioinformatics 21:3587\u20133595","journal-title":"Bioinformatics"},{"key":"4_CR17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/geno.2002.6698","volume":"79","author":"P Khatri","year":"2002","unstructured":"Khatri P, Draghici S, Ostermeier GC, Krawetz SA (2002) Profiling gene expression using onto-express. Genomics 79:266\u2013270","journal-title":"Genomics"},{"key":"4_CR18","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/gb-2003-4-4-r28","volume":"4","author":"BR Zeeberg","year":"2003","unstructured":"Zeeberg BR, Feng W, Wang G, Wang MD et al (2003) GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol 4:R28","journal-title":"Genome Biol"},{"key":"4_CR19","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1093\/bioinformatics\/bti260","volume":"21","author":"WT Barry","year":"2005","unstructured":"Barry WT, Nobel AB, Wright FA (2005) Significance analysis of functional categories in gene expression studies: a structured permutation approach. Bioinformatics 21:1943\u20131949","journal-title":"Bioinformatics"},{"key":"4_CR20","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545\u201315550","journal-title":"Proc Natl Acad Sci USA"},{"key":"4_CR21","doi-asserted-by":"crossref","first-page":"13544","DOI":"10.1073\/pnas.0506577102","volume":"102","author":"L Tian","year":"2005","unstructured":"Tian L, Greenberg SA, Kong SW, Altschuler J et al (2005) Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci USA 102:13544\u201313549","journal-title":"Proc Natl Acad Sci USA"},{"key":"4_CR22","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fphys.2013.00278","volume":"4","author":"C Mitrea","year":"2013","unstructured":"Mitrea C, Taghavi Z, Bokanizad B, Hanoudi S et al (2013) Methods and approaches in the topology-based analysis of biological pathways. Front Physiol 4:278","journal-title":"Front Physiol"},{"issue":"Suppl 5","key":"4_CR23","first-page":"61","volume":"13","author":"B Afsari","year":"2014","unstructured":"Afsari B, Geman D, Fertig EJ (2014) Learning dysregulated pathways in cancers from differential variability analysis. Cancer Inform 13(Suppl 5):61\u201367","journal-title":"Cancer Inform"},{"key":"4_CR24","doi-asserted-by":"crossref","first-page":"i390","DOI":"10.1093\/bioinformatics\/btn142","volume":"24","author":"JW Ho","year":"2008","unstructured":"Ho JW, Stefani M, dos Remedios CG, Charleston MA (2008) Differential variability analysis of gene expression and its application to human diseases. Bioinformatics 24:i390\u2013i398","journal-title":"Bioinformatics"},{"key":"4_CR25","doi-asserted-by":"crossref","first-page":"e1000792","DOI":"10.1371\/journal.pcbi.1000792","volume":"6","author":"JA Eddy","year":"2010","unstructured":"Eddy JA, Hood L, Price ND, Geman D (2010) Identifying tightly regulated and variably expressed networks by Differential Rank Conservation (DIRAC). PLoS Comput Biol 6:e1000792","journal-title":"PLoS Comput Biol"},{"key":"4_CR26","doi-asserted-by":"crossref","first-page":"e8064","DOI":"10.1371\/journal.pone.0008064","volume":"4","author":"J Zhang","year":"2009","unstructured":"Zhang J, Li J, Deng HW (2009) Identifying gene interaction enrichment for gene expression data. PLoS One 4:e8064","journal-title":"PLoS One"},{"key":"4_CR27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fgene.2014.00055","volume":"5","author":"AA Buzdin","year":"2014","unstructured":"Buzdin AA, Zhavoronkov AA, Korzinkin MB et al (2014) OncoFinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data. Front Genet 5:55","journal-title":"Front Genet"},{"key":"4_CR28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fmolb.2014.00008","volume":"1","author":"AA Buzdin","year":"2014","unstructured":"Buzdin AA, Zhavoronkov AA, Korzinkin MB et al (2014) The OncoFinder algorithm for minimizing the errors introduced by the high-throughput methods of transcriptome analysis. Front Mol Biosci 1:8","journal-title":"Front Mol Biosci"},{"key":"4_CR29","doi-asserted-by":"crossref","first-page":"9022","DOI":"10.18632\/oncotarget.2493","volume":"5","author":"K Lezhnina","year":"2014","unstructured":"Lezhnina K, Kovalchuk O, Zhavoronkov AA, Korzinkin MB et al (2014) Novel robust biomarkers for human bladder cancer based on activation of intracellular signaling pathways. Oncotarget 5:9022\u20139032","journal-title":"Oncotarget"},{"key":"4_CR30","doi-asserted-by":"crossref","first-page":"11345","DOI":"10.18632\/oncotarget.2489","volume":"5","author":"AM Aliper","year":"2014","unstructured":"Aliper AM, Frieden-Korovkina VP, Buzdin A et al (2014) Interactome analysis of myeloid-derived suppressor cells in murine models of colon and breast cancer. Oncotarget 5:11345\u201311353","journal-title":"Oncotarget"},{"key":"4_CR31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.18632\/aging.100717","volume":"7","author":"AM Aliper","year":"2015","unstructured":"Aliper AM, Csoka AB, Buzdin A, Jetka T et al (2015) Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells. Aging (Albany NY) 7:26\u201337","journal-title":"Aging (Albany NY)"},{"key":"4_CR32","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.18632\/aging.100711","volume":"6","author":"E Makarev","year":"2014","unstructured":"Makarev E, Cantor C, Zhavoronkov A, Buzdin A et al (2014) Pathway activation profiling reveals new insights into age-related macular degeneration and provides avenues for therapeutic interventions. Aging (Albany NY) 6:1064\u20131075","journal-title":"Aging (Albany NY)"},{"issue":"18","key":"4_CR33","doi-asserted-by":"crossref","first-page":"25150","DOI":"10.18632\/oncotarget.7209","volume":"7","author":"E Alexandrova","year":"2016","unstructured":"Alexandrova E, Nassa G, Corleone G, Buzdin A et al (2016) Large-scale profiling of signalling pathways reveals an asthma specific signature in bronchial smooth muscle cells. Oncotarget 7(18):25150\u201325161. [Epub ahead of print]","journal-title":"Oncotarget"},{"key":"4_CR34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.18632\/oncotarget.6394","volume":"7","author":"D Shepelin","year":"2016","unstructured":"Shepelin D, Korzinkin M, Vanyushina A, Aliper A et al (2016) Molecular pathway activation features linked with transition from normal skin to primary and metastatic melanomas in human. Oncotarget 7:656\u2013670","journal-title":"Oncotarget"},{"key":"4_CR35","first-page":"1052","volume":"49","author":"TD Lebedev","year":"2015","unstructured":"Lebedev TD, Spirin PV, Suntsova MV, Ivanova AV et al (2015) Receptor tyrosine kinase KIT may regulate expression of genes involved in spontaneous regression of neuroblastoma. Mol Biol (Mosk) 49:1052\u20131055","journal-title":"Mol Biol (Mosk)"},{"key":"4_CR36","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1073\/pnas.1517562113","volume":"113","author":"DR Ram","year":"2016","unstructured":"Ram DR, Ilyukha V, Volkova T, Buzdin A et al (2016) Balance between short and long isoforms of cFLIP regulates Fas-mediated apoptosis in vivo. Proc Natl Acad Sci USA 113:1606\u20131611","journal-title":"Proc Natl Acad Sci USA"},{"key":"4_CR37","first-page":"824","volume":"48","author":"KS Vishniakova","year":"2014","unstructured":"Vishniakova KS, Babizhaev MA, Aliper AM, Buzdin AA et al (2014) Stimulation of proliferation by carnosine: cellular and transcriptome approaches. Mol Biol 48:824\u2013833","journal-title":"Mol Biol"},{"issue":"11","key":"4_CR38","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1038\/leu.2014.130","volume":"28","author":"PV Spirin","year":"2014","unstructured":"Spirin PV, Lebedev TD, Orlova NN, Gornostaeva AS (2014) Silencing AML1-ETO gene expression leads to simultaneous activation of both pro-apoptotic and proliferation signaling. Leukemia 28(11):2222\u20132228","journal-title":"Leukemia"},{"issue":"5","key":"4_CR39","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/15384101.2016.1147633","volume":"15","author":"AV Artcibasova","year":"2016","unstructured":"Artcibasova AV, Korzinkin MB, Sorokin MI, Shegay PV et al (2016) MiRImpact, a new bioinformatic method using complete microRNA expression profiles to assess their overall influence on the activity of intracellular molecular pathways. Cell Cycle 15(5):689\u2013698","journal-title":"Cell Cycle"},{"key":"4_CR40","doi-asserted-by":"crossref","first-page":"27227","DOI":"10.18632\/oncotarget.4507","volume":"6","author":"LS Venkova","year":"2015","unstructured":"Venkova LS, Aliper AM, Suntsova M, Kholodenko R et al (2015) Combinatorial high-throughput experimental and bioinformatics approach identifies molecular pathways linked with the sensitivity to anticancer target drugs. Oncotarget 6:27227\u201327238","journal-title":"Oncotarget"},{"key":"4_CR41","doi-asserted-by":"crossref","first-page":"29347","DOI":"10.18632\/oncotarget.5119","volume":"6","author":"A Artemov","year":"2015","unstructured":"Artemov A, Aliper A, Korzinkin M, Lezhnina K et al (2015) A method for predicting target drug efficiency in cancer based on the analysis of signaling pathway activation. Oncotarget 6:29347\u201329356","journal-title":"Oncotarget"},{"key":"4_CR42","doi-asserted-by":"crossref","first-page":"15009","DOI":"10.1038\/hgv.2015.9","volume":"2","author":"Q Zhu","year":"2015","unstructured":"Zhu Q, Izumchenko E, Aliper AM, Makarev E (2015) Pathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patients. Hum Genome Var 2:15009","journal-title":"Hum Genome Var"},{"key":"4_CR43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","volume":"19","author":"BM Bolstad","year":"2003","unstructured":"Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185\u2013193","journal-title":"Bioinformatics"},{"key":"4_CR44","doi-asserted-by":"crossref","first-page":"D78","DOI":"10.1093\/nar\/gkt1266","volume":"42","author":"SD Hsu","year":"2014","unstructured":"Hsu SD, Tseng YT, Shrestha S, Lin YL et al (2014) miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res 42:D78\u2013D85","journal-title":"Nucleic Acids Res"},{"key":"4_CR45","doi-asserted-by":"crossref","first-page":"D222","DOI":"10.1093\/nar\/gkr1161","volume":"40","author":"T Vergoulis","year":"2012","unstructured":"Vergoulis T, Vlachos IS, Alexiou P, Georgakilas G et al (2012) TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res 40:D222\u2013D229","journal-title":"Nucleic Acids Res"},{"key":"4_CR46","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/annonc\/mdl492","volume":"18","author":"A Keshaviah","year":"2007","unstructured":"Keshaviah A, Dellapasqua S, Rotmensz N, Lindtner J et al (2007) CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials. Ann Oncol 18:701\u2013708","journal-title":"Ann Oncol"},{"key":"4_CR47","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.18632\/oncotarget.890","volume":"3","author":"MV Blagosklonny","year":"2012","unstructured":"Blagosklonny MV (2012) Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI\u2019s provocative questions. Oncotarget 3:1711\u20131724","journal-title":"Oncotarget"},{"key":"4_CR48","doi-asserted-by":"crossref","first-page":"10198","DOI":"10.18632\/oncotarget.2548","volume":"5","author":"NM Borisov","year":"2014","unstructured":"Borisov NM, Terekhanova NV, Aliper SM, Venkova LS et al (2014) Signaling pathways activation profiles make better markers of cancer than expression of individual genes. Oncotarget 5:10198\u201310205","journal-title":"Oncotarget"},{"key":"4_CR49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3758\/BF03199711","volume":"23","author":"JA Swets","year":"1978","unstructured":"Swets JA, Green DM, Getty DJ, Swets JB (1978) Signal detection and identification at successive stages of observation. Percept Psychophys 23:275\u2013289","journal-title":"Percept Psychophys"},{"key":"4_CR50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/00365519709168308","volume":"227","author":"JC Boyd","year":"1997","unstructured":"Boyd JC (1997) Mathematical tools for demonstrating the clinical usefulness of biochemical markers. Scand J Clin Lab Invest Suppl 227:46\u201363","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"4_CR51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/1947601913485414","volume":"4","author":"A Munshi","year":"2013","unstructured":"Munshi A, Ramesh R (2013) Mitogen-activated protein kinases and their role in radiation response. Genes Cancer 4:401\u2013408","journal-title":"Genes Cancer"},{"key":"4_CR52","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.18632\/oncotarget.2123","volume":"5","author":"A Morgenroth","year":"2014","unstructured":"Morgenroth A, Vogg AT, Ermert K et al (2014) Hedgehog signaling sensitizes glioma stem cells to endogenous nano-irradiation. Oncotarget 5:5483\u20135493","journal-title":"Oncotarget"},{"key":"4_CR53","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74\u2013108","journal-title":"CA Cancer J Clin"},{"key":"4_CR54","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00345-009-0383-3","volume":"27","author":"M Ploeg","year":"2009","unstructured":"Ploeg M, Aben KK, Kiemeney LA (2009) The present and future burden of urinary bladder cancer in the world. World J Urol 27:289\u2013293","journal-title":"World J Urol"},{"key":"4_CR55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fgene.2013.00247","volume":"4","author":"AA Zabolotneva","year":"2013","unstructured":"Zabolotneva AA, Zhavoronkov AA, Shegay PV, Gaifullin NM (2013) A systematic experimental evaluation of microRNA markers of human bladder cancer. Front Genet 4:247","journal-title":"Front Genet"},{"key":"4_CR56","unstructured":"Jerant AF, Johnson JT, Sheridan CD, Caffrey TJ (2000) Early detection and treatment of skin cancer. Am Fam Physician 62:357\u2013368, 375\u2013376, 381\u2013382"},{"key":"4_CR57","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1470-2045(09)70213-X","volume":"10","author":"F Ghissassi El","year":"2009","unstructured":"El Ghissassi F, Baan R, Straif K, Grosse Y (2009) A review of human carcinogens\u2014part D: radiation. Lancet Oncol 10:751\u2013752","journal-title":"Lancet Oncol"},{"key":"4_CR58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00001622-200103000-00008","volume":"13","author":"S Halachmi","year":"2001","unstructured":"Halachmi S, Gilchrest BA (2001) Update on genetic events in the pathogenesis of melanoma. Curr Opin Oncol 13:129\u2013136","journal-title":"Curr Opin Oncol"},{"key":"4_CR59","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1038\/onc.2010.323","volume":"29","author":"MA Davies","year":"2010","unstructured":"Davies MA, Samuels Y (2010) Analysis of the genome to personalize therapy for melanoma. Oncogene 29:5545\u20135555","journal-title":"Oncogene"},{"key":"4_CR60","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/028418699431113","volume":"38","author":"D Elder","year":"1999","unstructured":"Elder D (1999) Tumor progression, early diagnosis and prognosis of melanoma. Acta Oncol 38:535\u2013547","journal-title":"Acta Oncol"},{"key":"4_CR61","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1200\/JCO.2014.56.0896","volume":"32","author":"N Hanna","year":"2014","unstructured":"Hanna N, Einhorn LH (2014) Testicular cancer: a reflection on 50 years of discovery. J Clin Oncol 32:3085\u20133092","journal-title":"J Clin Oncol"},{"key":"4_CR62","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1128\/JVI.65.8.4190-4197.1991","volume":"65","author":"L Svensson","year":"1991","unstructured":"Svensson L, Finlay BB, Bass D et al (1991) Symmetric infection of rotavirus on polarized human intestinal epithelial (Caco-2) cells. J Virol 65:4190\u20134197","journal-title":"J Virol"},{"key":"4_CR63","first-page":"605","volume":"73","author":"NV Zhukov","year":"2008","unstructured":"Zhukov NV, Tjulandin SA (2008) Targeted therapy in the treatment of solid tumors: practice contradicts theory. Biochemistry 73:605\u2013618","journal-title":"Biochemistry"},{"key":"4_CR64","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nature03095","volume":"432","author":"C Sawyers","year":"2004","unstructured":"Sawyers C (2004) Targeted cancer therapy. Nature 432:294\u2013297","journal-title":"Nature"},{"key":"4_CR65","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1038\/sj.onc.1210379","volume":"26","author":"R Nahta","year":"2007","unstructured":"Nahta R, Esteva FJ (2007) Trastuzumab: triumphs and tribulations. Oncogene 26:3637\u20133643","journal-title":"Oncogene"},{"key":"4_CR66","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3121\/cmr.2008.825","volume":"7","author":"AA Onitilo","year":"2009","unstructured":"Onitilo AA, Engel JM, Greenlee RT, Mukesh BN (2009) Breast cancer subtypes based on ER\/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res 7:4\u201313","journal-title":"Clin Med Res"},{"key":"4_CR67","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman PB, Hauschild A, Robert C, Haanen JB et al (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364:2507\u20132516","journal-title":"N Engl J Med"},{"key":"4_CR68","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1158\/1078-0432.CCR-11-1823","volume":"18","author":"PA Prieto","year":"2012","unstructured":"Prieto PA, Yang JC, Sherry RM, Hughes MS (2012) CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma. Clin Cancer Res 18:2039\u20132047","journal-title":"Clin Cancer Res"},{"key":"4_CR69","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.lungcan.2010.12.008","volume":"71","author":"C Gridelli","year":"2011","unstructured":"Gridelli C, De Marinis F, Di Maio M, Cortinovis D et al (2011) Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: review of the evidence. Lung Cancer 71:249\u2013257","journal-title":"Lung Cancer"},{"key":"4_CR70","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1200\/JCO.2011.40.4194","volume":"30","author":"A Grothey","year":"2012","unstructured":"Grothey A, Lenz HJ (2012) Explaining the unexplainable: EGFR antibodies in colorectal cancer. J Clin Oncol 30:1735\u20131737","journal-title":"J Clin Oncol"},{"key":"4_CR71","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ et al (2013) Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res 41:D955\u2013D956","journal-title":"Nucleic Acids Res"},{"key":"4_CR72","unstructured":"GEO Profiles, a National Center of Biotechnology Information database. http:\/\/www.ncbi.nlm.nih.gov\/geo\/ . Accessed 16 Mar 2016"},{"key":"4_CR73","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1093\/nar\/gkr407","volume":"39","author":"B Reva","year":"2011","unstructured":"Reva B, Antipin Y, Sander C (2011) Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res 39:e118","journal-title":"Nucleic Acids Res"}],"container-title":["Methods in Molecular Biology","Biological Networks and Pathway Analysis"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7027-8_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T11:54:17Z","timestamp":1602849257000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7027-8_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9781493970254","9781493970278"],"references-count":73,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7027-8_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}